Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2009 6
2010 1
2011 4
2012 1
2013 2
2014 6
2015 5
2016 5
2017 6
2018 6
2019 9
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition.
Castel P, Ellis H, Bago R, Toska E, Razavi P, Carmona FJ, Kannan S, Verma CS, Dickler M, Chandarlapaty S, Brogi E, Alessi DR, Baselga J, Scaltriti M. Castel P, et al. Among authors: kannan s. Cancer Cell. 2016 Aug 8;30(2):229-242. doi: 10.1016/j.ccell.2016.06.004. Epub 2016 Jul 21. Cancer Cell. 2016. PMID: 27451907 Free PMC article.
Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer.
Collins DM, Conlon NT, Kannan S, Verma CS, Eli LD, Lalani AS, Crown J. Collins DM, et al. Among authors: kannan s. Cancers (Basel). 2019 May 28;11(6):737. doi: 10.3390/cancers11060737. Cancers (Basel). 2019. PMID: 31141894 Free PMC article. Review.
Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513.
Wong YH, Kumar A, Liew CW, Tharakaraman K, Srinivasaraghavan K, Sasisekharan R, Verma C, Lescar J. Wong YH, et al. Among authors: srinivasaraghavan k. Sci Rep. 2018 May 31;8(1):8449. doi: 10.1038/s41598-018-26800-y. Sci Rep. 2018. PMID: 29855525 Free PMC article.
Probing the dynamics of disorder.
Fox SJ, Kannan S. Fox SJ, et al. Among authors: kannan s. Prog Biophys Mol Biol. 2017 Sep;128:57-62. doi: 10.1016/j.pbiomolbio.2017.05.008. Epub 2017 May 26. Prog Biophys Mol Biol. 2017. PMID: 28554553 Review.
AKT signaling in ERBB2-amplified breast cancer.
Carmona FJ, Montemurro F, Kannan S, Rossi V, Verma C, Baselga J, Scaltriti M. Carmona FJ, et al. Among authors: kannan s. Pharmacol Ther. 2016 Feb;158:63-70. doi: 10.1016/j.pharmthera.2015.11.013. Epub 2015 Dec 2. Pharmacol Ther. 2016. PMID: 26645663 Free PMC article. Review.
Incorporation of Putative Helix-Breaking Amino Acids in the Design of Novel Stapled Peptides: Exploring Biophysical and Cellular Permeability Properties.
Partridge AW, Kaan HYK, Juang YC, Sadruddin A, Lim S, Brown CJ, Ng S, Thean D, Ferrer F, Johannes C, Yuen TY, Kannan S, Aronica P, Tan YS, Pradhan MR, Verma CS, Hochman J, Chen S, Wan H, Ha S, Sherborne B, Lane DP, Sawyer TK. Partridge AW, et al. Among authors: kannan s. Molecules. 2019 Jun 20;24(12):2292. doi: 10.3390/molecules24122292. Molecules. 2019. PMID: 31226791 Free PMC article.
A Novel Determinant of PSMD9 PDZ Binding Guides the Evolution of the First Generation of Super Binding Peptides.
Harish M, Kannan S, Puttagunta S, Pradhan MR, Verma CS, Venkatraman P. Harish M, et al. Among authors: kannan s. Biochemistry. 2019 Aug 13;58(32):3422-3433. doi: 10.1021/acs.biochem.9b00308. Epub 2019 Jul 29. Biochemistry. 2019. PMID: 31287951
Effects of Single Nucleotide Polymorphisms on the Binding of Afatinib to EGFR: A Potential Patient Stratification Factor Revealed by Modeling Studies.
Kannan S, Tan DS, Verma CS. Kannan S, et al. J Chem Inf Model. 2019 Jan 28;59(1):309-315. doi: 10.1021/acs.jcim.8b00491. Epub 2018 Dec 10. J Chem Inf Model. 2019. PMID: 30481018
The Multifaceted Roles of Molecular Dynamics Simulations in Drug Discovery.
Fox SJ, Li J, Tan YS, Nguyen MN, Pal A, Ouaray Z, Yadahalli S, Kannan S. Fox SJ, et al. Among authors: kannan s. Curr Pharm Des. 2016;22(23):3585-600. doi: 10.2174/1381612822666160425120507. Curr Pharm Des. 2016. PMID: 27108593 Review.
52 results
Jump to page